Skip to main content

Effect of Hypouricemic Agents on Serum Carbohydrate-Deficient Transferrin in Gouty Patients

  • Chapter
Purine and Pyrimidine Metabolism in Man VIII

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 370))

Abstract

Carbohydrate-deficient transferrin (CDT) was demonstrated to be a reliable biochemical marker of alcohol abuse by Stibler et al(1, 2). CDT is currently regarded as the most accurate biological indicator of recent, heavy alcohol consumption. Alcohol consumption has been reported to be closely related to hyperuricemia and gout(3). The measurement of CDT in gouty patients is considered to be helpful on their management of hyperuricemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H. Stibler, Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed, Clin Chem 37: 2029 (1991).

    PubMed  CAS  Google Scholar 

  2. U.J. Behrens, T.M. Worner, L.F. Braly, et al, Carbohydrate-deficient transferrin, a marker for chronic alcohol consumption in different ethnic populations, Alcoh Clin Exp Res 12: 427 (1988).

    Article  CAS  Google Scholar 

  3. T. Gibson, A.V. Rodgers, H.A. Simmonds, et al, A controlled study of diet in patients with gout, Ann Rheum Dis 42:123 (1983).

    Article  PubMed  CAS  Google Scholar 

  4. K, Kaneko, S. Fujimori, I. Ishizuka, et al, Effect of ethanol on metabolism of the hypouricemic agents allopurinol and benzbromarone, Clin Chim Acta 193: 181 (1990).

    Article  PubMed  CAS  Google Scholar 

  5. H. Stibler and O. Sydow, Quantitative estimation of abnormal microheterogeneity of serum transferrin in alcoholics, Pharmacol Biochem Behav 13: 47 (1980).

    Article  PubMed  Google Scholar 

  6. H. Stibler, S. Borg, and M. Joustra, Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption, Alcoh Clin Exp Res 10: 535 (1986).

    Article  CAS  Google Scholar 

  7. K, Kaneko, S. Fujimori, H. Yamanaka, et al, Serum level of carbohydrate-deficient transferrin in gouty patients, (in press).

    Google Scholar 

  8. G.B. Elion, T.F. Yu, A.B. Gutman, et al, Renal clearance of oxipurinol, the chief metabolite of allopurinol, Am J Med 45: 69 (1968).

    Article  PubMed  CAS  Google Scholar 

  9. L.M. Fletcher, I. Kwoh-Gain, E.E. Powell, et al, Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis, Hepatol 13: 455 (1991).

    Article  CAS  Google Scholar 

  10. Y. Xin, A.S. Rosman, J.M. Lasker, et al, Measurement of carbohydrate-deficient transferrin by isoelectric focusing/western blotting and by micro anion exchange chromatography/radioimmunoassay: comparison of diagnostic accuracy, Alcoh Alcoh 27: 425 (1992).

    CAS  Google Scholar 

  11. C.R. Sharpe, A case-control study of alcohol consumption and drinking behavior in patients with acute gout, Can Med Assoc J 131: 56 (1984).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kaneko, K., Fujimori, S., Yamanaka, H., Akaoka, I. (1995). Effect of Hypouricemic Agents on Serum Carbohydrate-Deficient Transferrin in Gouty Patients. In: Sahota, A., Taylor, M.W. (eds) Purine and Pyrimidine Metabolism in Man VIII. Advances in Experimental Medicine and Biology, vol 370. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2584-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2584-4_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6105-3

  • Online ISBN: 978-1-4615-2584-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics